longbridge
  • Explore
    Products
    Private Wealth ManagementUS StocksSG StocksHK StocksUS OptionsUS Pre-Market OptionsETFsREITsWarrantsCash Plus
    Tools
    Longbridge SkillLongbridge AILongbridge APIPaper TradingDividend HubLongbridge Pro
  • Café
longbridge

EVEREST MED

01952

24.4402.24% ( -0.560 )
Delay Closed: Nov 18, 16:08:04
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile

News

  • Everest Medicines Adds Two Drugs to China's Reimbursement List

    TradingView·Nov 16, 2026 at 11:48 AM
    01952-2.24%
  • Everest Medicines Holds Extraordinary General Meeting

    PUBT·Nov 16, 2026 at 11:47 AM
    01952-2.24%
  • Weekly Recap | EVEREST MED -2.44%, consensus target above spot

    Weekly Review·Nov 14, 2026 at 05:14 AM
    01952-2.24%
  • BOCOM International Holdings Company Sticks to Their Buy Rating for Everest Medicines Ltd. (1952)

    Tip Ranks·Nov 13, 2026 at 12:25 PM
    01952-2.24%
  • What Investors Overlooked Before Everest Medicines Slid

    Simplywall·Nov 13, 2026 at 06:47 AM
    01952-2.24%
  • China Approves New 100 mg XERAVA® Strength for Adult cIAI

    Tip Ranks·Nov 12, 2026 at 11:26 PM
    01952-2.24%
  • Weekly Recap | EVEREST MED +0.3%, most brokers rate it buy

    Weekly Review·Nov 7, 2026 at 05:36 AM
    01952-2.24%
  • Everest Medicines climbs 6%

    Market Movers·Nov 5, 2026 at 01:31 AM
    01952-2.24%
  • Everest Medicines falls 6% in Hong Kong trading

    Market Movers·Nov 3, 2026 at 05:49 AM
    01952-2.24%
  • Everest Medicines Seeks Shareholder Approval for Strategic Cooperation Agreement With Hasten

    PUBT·Oct 30, 2026 at 09:08 AM
    01952-2.24%
LongbridgeAI
© 2026 Longbridge|Terms of ServicePrivacy Policy